Hormone Use Linked to Increased Breast Cancer Risk Among Black Women

	Tweet

Hormone therapy appears to be associated with increased risk of breast cancer among black women, with a stronger link for leaner women, according to a study in the April 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Previous research has suggested that the long-term use of female hormone therapy is associated with an increased risk of developing breast cancer, according to background information in the article. However, most of the women in the largest studies have been white, and few studies have looked at the risks specifically in black women.

Lynn Rosenberg, Sc.D., of Slone Epidemiology Center, Boston University, and colleagues examined the association in 23,191 women age 40 years or older who were part of the Black Women’s Health Study, conducted by investigators at Boston University and Howard University, Washington, D.C.

The participants filled out an initial questionnaire about medical history, menopausal status and hormone use when they enrolled in the study in 1995. Follow-up questionnaires that also included questions about the development of breast cancer were completed every two years through the year 2003. The women’s body mass index (BMI) was calculated by dividing their weight in kilograms by the square of their height in meters.

During the course of the study, 615 cases of breast cancer were reported. Breast cancer was more likely to occur in women who had taken hormones, including estrogen or estrogen plus progestin, in the previous two years than in women who had never taken hormones. The longer a woman took hormones, the more likely she was to develop breast cancer, and the risk was slightly higher for women taking estrogen with progestin than for those taking progestin alone. The association between hormone use and breast cancer was strongest for women who were lean, defined as having a BMI of less than 25.

“Associations of exogenous [supplemental] female hormone use with increased risk of breast cancer are biologically plausible,” the authors write. Estrogens produced by the body are associated with the development of breast cancer, and progestin is known to induce cell division in breast tissue, which could lead to a higher risk of cancer. The relationship may be stronger in lean women because fat tissue produces estrogen, so the extra hormones added by taking pills may not have as much of an effect on estrogen levels in heavier women.

“These results based on data from U.S. black women strengthen the evidence that use of estrogen alone and estrogen with progestin increases the risk of breast cancer and that the association is stronger among leaner women,” the authors conclude.

(Arch Intern Med. 2006; 166: 760-765.
http://www.jamamedia.org

RELATED STORIES:
Obesity, estrogen breakdown tied to breast cancer   Causes of Bone Loss in Breast Cancer Survivors Identified   Newly Developed Prediction Tool Helps Estimate Local Recurrence in Patients with Non-Invasive Breast Cancer   Testing misses some breast cancer mutations   Hybrid vaccine demonstrates potential to prevent breast cancer recurrence   Breast symmetry can be early indicator of breast cancer   “Pre-vivors” Beat Cancer to the Punch   Adjuvant hormonal therapy reduces contralateral breast cancer risk   Left-handed women’s risk of breast cancer higher-study   Researcher to Study Role of Race in Breast Cancer   Radiotherapy aids breast cancer survival: study   Fruits And Veggies Don’t Prevent Breast Cancer Recurrence   Women with personal history of breast cancer should be screened with MRI   Aluminum salts may increase breast cancer risk   Stopping hormones might help breast cancer to regress   IMRT reduces risk of side effects in breast cancer patients   Novel Breast Tissue Feature may Predict Woman’s Cancer Risk   Estrogen therapy linked to benign breast disease   Meat, dairy and breast cancer: new findings   Yoga study shows some benefits for cancer patients   CSHL team identifies enzyme that is an important regulator of aggressive breast cancer development   Associations Between Pregnancy, Breastfeeding, Breast Cancer and Survival Detailed

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]